These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer. Schneider J; Philipp M; Salewski L; Velcovsky HG Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474 [TBL] [Abstract][Full Text] [Related]
7. Serum neurone-specific enolase and other neuroendocrine markers in lung cancer. Ledermann JA Eur J Cancer; 1994; 30A(5):574-6. PubMed ID: 8080666 [No Abstract] [Full Text] [Related]
8. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Pujol JL; Quantin X; Jacot W; Boher JM; Grenier J; Lamy PJ Lung Cancer; 2003 Feb; 39(2):131-8. PubMed ID: 12581564 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer]. Yang J; Li R; Li A Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of "neuron-specific enolase" as a tumor marker for small cell carcinoma of the lung. Güner G; Oktay G; Akkoçlu A; Karlikaya C Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):306S. PubMed ID: 8224452 [No Abstract] [Full Text] [Related]
11. Value of tumour and inflammatory markers in lung cancer. Oremek GM; Sauer-Eppel H; Bruzdziak TH Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794 [TBL] [Abstract][Full Text] [Related]
12. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases. Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318 [TBL] [Abstract][Full Text] [Related]
13. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer. Oremek GM; Sapoutzis N Anticancer Res; 2003; 23(2A):895-8. PubMed ID: 12820319 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer. Nisman B; Heching N; Biran H; Barak V; Peretz T Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer. Okusaka T; Eguchi K; Kasai T; Kurata T; Yamamoto N; Ohe Y; Tamura T; Shinkai T; Saijo N Clin Cancer Res; 1997 Jan; 3(1):123-7. PubMed ID: 9815547 [TBL] [Abstract][Full Text] [Related]
17. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer. Huang Z; Xu D; Zhang F; Ying Y; Song L Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220 [TBL] [Abstract][Full Text] [Related]
18. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer? Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424 [TBL] [Abstract][Full Text] [Related]